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PRELIMINARY CLINICAL RESULTS OF IMPLANTATION OF BIODEGRADABLE PERICARDIAL 
SUBSTITUTE IN PEDIATRIC OPEN HEART OPERATIONS 
Afksendiyos Kalangos, MD, PhD, and Bernard Faidutti, MD, Geneva, Switzerland 
An increasing number of repeat operations done for 
various reasons has forced surgeons to face the problem of 
pericardial adhesions that could place some sites of the 
heart at risk during repeat sternotomy. Therefore various 
pericardial substitutes have been developed and tested 
with long-term clinical outcomes not well known. Re- 
cently, a new concept based on the regenerative potential 
of pericardial mesothelium onto a biodegradable patch 
has been the focus of great enthusiasm after the experi- 
mental study done by Malm and associates. 1" z In their 
study, the effects of the biodegradable polyhydroxybu- 
tyrate (PHB) patch on adhesion formation, preservation 
of the coronary anatomy, and pericardial regeneration 
were investigated. In animals treated with PHB patches, 
the adhesion formation was minimized and the visibility of 
coronary anatomy was preserved significantly as a result of 
the demonstrated fact that the patch could act as a 
scaffold for regeneration of mesothelium-like c lls with 
preserved prostacyclin activity. 1 However, since the clini- 
cal application of this patch (provided by Astra Meditec, 
M61ndal, Sweden) was first done, no evaluation for adhe- 
sion development and epicardial reaction to this patch in 
human beings has been reported, certainly because of a 
limited number of cases of reoperation i which the patch 
was implanted. 
Since 1992 the biodegradable PHB patch was used in 
our institution as a pericardial substitute in 65 pediatric 
cases that required open heart operations because of 
various congenital lesions. In all these cases the anterior 
autologous pericardium was resected in order to be used 
either in the reconstruction of the right ventricular (RV) 
outflow tract or in the closure of ventricular septal defects. 
The PHB patch was applied before sternal closure at the 
site of the harvested pericardium by interrupted 5-0 
monofilament stitches to the edge of the native pericar- 
diam. Two drains were placed into the mediastinum after 
the patch was spread as smoothly as possible over the 
anterior and inferior surfaces of the RV, ascending aorta, 
and part of the pulmonary artery. 
To date, five children have required reoperation be- 
cause of various reasons: residual or recurrent RV outflow 
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tract stenosis in three cases, residual ventricular septal 
defect in one case, and RV aneurysm formation in one 
case. The mean interval between the two operations was 
186.4 days (range 76 to 471 days). No excessive postoper- 
ative bleeding or infections were noted after the first 
operation. Four children who underwent reoperation af- 
ter a mean duration of 115.2 days (range 76 to 154 days) 
were evaluated for adhesion formation and visibility of 
coronary anatomy. In these cases at the time of reopera- 
tion, adhesions between the sternum and PHB patch and 
between the area of the patch and epicardium were 
graded as moderate. Adhesions between native pericar- 
dium and epicardium were also evaluated as moderate 
except in one case in which the native pericardium was 
severely adhered to a previously implanted aortic ho- 
mograft. In these four cases, the visibility of the coronary 
anatomy was blurred in both epicardial areas in contact 
with the PHB patch and native pericardium. At the time 
of reoperation, the patch had an aspect of a fibrinous 
capsule covering the epicardial surface that allowed the 
underlying anatomy to be distinguished during the dissec- 
tion, which did not result in bleeding. There was not a 
clear demarcation at the level of the suture line between 
patch and native pericardium. No histologic specimens of 
the patch or epicardium were obtained. 
In the last case, that of a 2-year-old child who had 
initially undergone correction of tetralogy of Fallot with 
an aortic homograft implantation between the RV and 
pulmonary artery bifurcation, a significant stenosis devel- 
oped at the site of anastomosis between the RV and 
homograft 14 months after operation. At the time of 
reoperation 16 months after operation, no adhesions 
between the sternum and anterior RV epicardium were 
noted after resternotomy. The PHB patch was completely 
absorbed and the underlying anatomy at the site of patch 
implantation was clearly recognizable. On the contrary, 
severe adhesions between ative pericardium and under- 
lying heart structures and especially the homograft neces- 
sitated a sharp dissection that resulted in bleeding. 
Our preliminary clinical results suggest hat the PHB 
patch was well tolerated and remained basically as a 
fibrinous ac maintaining an acceptable plane of cleavage 
between the patch and epicardium in the first 5 months 
after operation. Absorption of the patch probably occurs 
more rapidly in human beings than was observed in 
animals. 1 Of course, this time-related phenomenon is also 
related to the severity of the early postoperative inflam- 
matory reaction, which will be more pronounced in cases 
with anatomic and biologic structural tissue modifications 
caused by several cardiac incisions or suture lines with the 
use of cardiopulmonary b pass. In the first few months 
after operation, the severity of the inflammatory eaction 
and number of macrophages will regress proportionally to
the absorbed amount of polymer and to increased func- 
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tional properties of the regenerated mesothelium-like 
cells that could better stimulate and facilitate the absorp- 
tion. We believe that adhesion formation and functional 
activity of the regenerated tissue onto the PHB patch 
should be reevaluated in an experimental study under 
conditions resembling those of open heart operations in 
human beings. A more detailed analysis of the interaction 
between the biodegradable patch and epicardium should 
be considered with the enhanced inflammatory reaction 
induced by cardiopulmonary b pass and surgical trauma. 
Moreover, why could one not create biodegradable 
patches oaked in some antiinflammatory substances such 
as protease inhibitors that could attenuate postbypass 
inflammatory reactions? 
On the basis of our preliminary clinical experience, the 
biodegradable patch seems to be an interesting material 
as a pericardial substitute in patients who might require 
reoperation in the medium or long term when primary 
pericardial closure is not possible. 
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STERNAL HEMANGIOMA: A RARE TUMOR 
Benjamin Medalion, MD, a Ilan Bar, MD, a Rami Neuman, MD, b Yaron Shargal, MD, a and Gideon Merin, MD, a 
Jerusalem, Israel 
Primary tumors of the bony chest wall are uncommon. 1 
Among those tumors, sternal tumors are extremely rare 2 
and usually malignant. 2' 3 In this case report, we discuss a 
benign hemangioma of the sternum in a 30-year-old 
woman who had a 2-year history of chest pain without 
objective physical findings. She underwent a bone scan, 
with results regarded as normal. Computed tomography 
demonstrated a round mass in the body of the sternum 
(Fig. 1,A). On magnetic resonance imaging (Fig. 1, B), the 
mass was found to be located in the lower part of the 
sternal body to invade the sternal cortex. An open biopsy 
sampling of the mass was performed elsewhere, and a 
benign hemangioma was diagnosed. During the biopsy 
procedure, the patient had extensive bleeding, which was 
finally controlled. 
Subsequent magnetic resonance imaging 2 months later 
demonstrated anenlargement of the mass, and she had an 
elective operation. The left and right internal thoracic 
arteries were divided at the manubrium. Each costochon- 
dral junction was divided on both sides after the intercos- 
tal vessels had been ligated and divided. The sternum was 
transected transversely through the second intercostal 
space; the resected sternum and the mass were then 
separated from the mediastinum and removed. The pec- 
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toralis major muscles were mobilized and used as in situ 
flaps to close the wound. 
The patient had uneventful operative and postoperative 
courses and went home 8 days after the operation. Histo- 
logic examination of the mass revealed an encapsulated 
5 × 5 × 9 cm hemangioma that replaced almost he entire 
resected sternum. At 6-month follow-up the patient had 
regained a normal lifestyle, with no chest pain and no 
signs of recurrence. 
A search of the literature revealed only one similar 
case, that of a 38-year-old woman who reported pain in 
the midanterior area of the chest. 4 This patient had a 
history of similar intermittent pain for 15 years. Physical 
examination revealed only slight prominence and tender- 
ness of the superior aspect of the sternal body. The patient 
underwent a surgical excision of the sternal lesion. 
Benign sternal tumors are extremely rare, and all 
sternal tumors should be considered malignant until 
proved otherwise. 4 Hemangiomas of the chest wall are 
most often encountered in the vertebra, ribs, and skeletal 
muscles. 5 Although hemangiomas are quite common tu- 
mors, no hemangiomas of the sternum have been de- 
scribed except for the case published by Boker and 
coworkers 4 and the case described here by us. Irradiation 
therapy, interferon therapy, and selective mbolization of 
feeding vessels have been suggested as alternatives to 
surgical treatment, especially for children and patients 
with hemangiomas of the skin. 6-8 Because there is no 
sharp distinction between benign hemangiomas nd low- 
grade malignant hemangioendotheliomas and because of 
the relatively high recurrence rate of hemangiomas, 5 we 
decided to operate on this patient and to resect he tumor 
with adjacent sternal tissue. 
